Valuation: CellaVision AB

Market Cap 3.49B 362M 316M 291M 271M 514M 34.47B 522M 1.36B 16.94B 1.36B 1.33B 58.39B P/E 2026 *
24.1x
P/E 2027 * 19.7x
Enterprise Value 3.28B 340M 297M 273M 254M 482M 32.34B 490M 1.27B 15.9B 1.28B 1.25B 54.78B EV / Sales 2026 *
4.26x
EV / Sales 2027 * 3.75x
Free-Float
83.08%
Yield 2026 *
1.93%
Yield 2027 * 2.15%
1 day+3.78%
1 week+5.48%
Current month+7.49%
1 month+21.39%
3 months-3.05%
6 months-3.17%
Current year-6.87%
1 week 133.8
Extreme 133.8
147.8
1 month 120
Extreme 120
154.4
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 59.5
Extreme 59.5
503.5
Manager TitleAgeSince
Chief Executive Officer - 2026-06-04
Director of Finance/CFO 46 2025-09-01
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 2018-05-03
Chairman 64 2021-04-28
Date Insider Type Main position Quantity % Market Cap.
Jun. 11Buy 760 0.0032%
Jun. 08Buy

Director

314 0.0013%
Jun. 08Buy

Founder

33,000 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
+2.52%+5.48%-20.26%-20.26% 353M
-1.95%-1.56%+1.21%-28.54% 16.67B
+5.89%+17.22%+43.79%+99.43% 1.68B
+0.39%+34.99%-39.53%-77.97% 1.24B
+0.06%+3.18%-28.32%+31.12% 1.14B
+1.31%-0.09%-25.81%-52.92% 631M
+0.21%-0.98%-39.13%-56.82% 580M
-0.66%+3.11%+21.67%-54.99% 447M
+1.79%-1.42%-55.45%-60.47% 375M
-2.14%-3.23%+31.57%+26.68% 329M
Average +0.84%+5.57%-11.03%-19.47% 2.35B
Weighted average by Cap. -0.98%+3.59%-1.47%-20.55%

Financials

2026 *2027 *
Net sales 769M 79.72M 69.69M 64.04M 59.7M 113M 7.59B 115M 299M 3.73B 299M 293M 12.86B 862M 89.34M 78.1M 71.78M 66.9M 127M 8.51B 129M 335M 4.18B 335M 328M 14.41B
Net income 141M 14.64M 12.8M 11.76M 10.96M 20.79M 1.39B 21.11M 54.88M 685M 54.94M 53.77M 2.36B 177M 18.31M 16.01M 14.71M 13.71M 26.01M 1.74B 26.41M 68.66M 857M 68.74M 67.26M 2.95B
Net Debt -216M -22.37M -19.55M -17.97M -16.75M -31.77M -2.13B -32.25M -83.86M -1.05B -83.95M -82.15M -3.61B -261M -27.11M -23.7M -21.78M -20.3M -38.5M -2.58B -39.08M -102M -1.27B -102M -99.56M -4.37B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
241
Date Price Change Volume
26-07-03 SEK 146.40 +2.52% 29,129
26-07-02 SEK 142.80 +4.23% 20,770
26-07-01 SEK 137.00 +0.59% 21,048
26-06-30 SEK 136.20 +0.59% 17,534
26-06-29 SEK 135.40 -0.44% 25,936
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
146.40SEK
Average target price
177.75SEK
Spread / Average Target
+21.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock